earnings
confidence high
sentiment neutral
materiality 0.75
Outset Medical Q4 revenue $28.2M, FY21 $102.6M (+105%); guides FY22 $142-150M; CEO adds Chair
Outset Medical, Inc.
2022-FY EPS reported
-$2.89
revenue$102,602,000
- Q4 revenue $28.2M (+63% YoY); FY21 revenue $102.6M (+105.5% YoY). GAAP EPS ($0.87); non-GAAP EPS ($0.77).
- FY21 GAAP net loss $131.9M ($2.89/share); non-GAAP net loss $114.5M ($2.51/share).
- Q4 gross margin 11.8% (vs 2.4% YoY); cash and investments $372.8M at Dec 31, 2021.
- FY2022 revenue guidance $142M-$150M representing 38%-46% growth over FY2021.
- CEO Leslie Trigg appointed Chair of Board; D. Keith Grossman becomes Lead Independent Director.